Ibuprofen liquigel for oral surgery pain

Area of Science:

• Pharmacology
• Pain Management
• Clinical Trials

Background:

• Ibuprofen liquigel, a solubilized potassium ibuprofen formulation, has been available over-the-counter since 1995.
• Postoperative dental pain, specifically after impacted third molar removal, presents a significant clinical challenge.

Purpose of the Study:

• To compare the analgesic efficacy and tolerability of ibuprofen liquigel (200 mg and 400 mg) against acetaminophen (1000 mg) and placebo.
• To evaluate pain relief, pain intensity reduction, and onset of analgesia in patients with moderate to severe postoperative pain.

Main Methods:

• A randomized, double-blind, parallel-group study involving 210 patients with moderate to severe pain post-third molar extraction.
• Pain intensity and relief were systematically recorded over 6 hours, with specific attention to the onset of perceptible and meaningful pain relief.
• Statistical analyses included ANOVA for efficacy measures and Cox proportional hazards model for onset data; adverse events were monitored for tolerability.

Main Results:

• All active treatments (ibuprofen liquigel 200 mg, ibuprofen liquigel 400 mg, acetaminophen 1000 mg) showed significantly greater efficacy than placebo within the first 2 hours.
• Both ibuprofen liquigel doses were significantly more effective than acetaminophen 1000 mg for both short-term (2 hours) and long-term (6 hours) pain relief.
• Ibuprofen liquigel 400 mg demonstrated a significantly faster onset of meaningful pain relief compared to acetaminophen 1000 mg.

Conclusions:

• Ibuprofen liquigel provided superior peak and overall analgesic effects compared to acetaminophen 1000 mg.
• The study confirmed a more rapid onset of analgesia with ibuprofen liquigel, particularly at the 400 mg dose.
• Ibuprofen liquigel was found to be a more effective analgesic option for moderate to severe postoperative pain than acetaminophen.